Baoru Fang, Siqi Geng, Ke Wang, Fang Wang, Yiqing Zhou, Jiaying Qin, Shengnan Lou, Yanping Chen, Zhangsen Yu(*), Phosphomolybdenum Blue Nano-Photothermal Agent with Dual Peak Absorption and Biodegradable Properties Based on ssDNA in Near-Infrared Photothermal Therapy for Breast Cancer, Nanoscale Horizons, 2025, DOI: 10.1039/d4nh00464g.
Fang Wang, Ke Wang, Baoru Fang, Siqi Geng, Ying Li, Huifeng Qian, Yinuo Li(*), Zhangsen Yu(*), Hollow Mesoporous Prussian Blue Nanozymes Alleviate Doxorubicin-Induced Cardiotoxicity by Restraining Oxidative Stress Associated with Nrf2 Signaling, Journal of Colloid and Interface Science, 2025, 686: 1074-1088.
Siqi Geng, Baoru Fang, Ke Wang, Fang Wang, Yiqing Zhou, Yike Hou, M. Zubair Iqbal, Yanping Chen, Zhangsen Yu(*), Polydopamine Nanoformulations Inuced ICD and M1 Phenotype Macrophage Polarization for Enhanced TNBC Synergistic Photothermal Immunotherapy, ACS Applied Materials & Interfaces, 2024, 16(44): 59814-59832.
Ke Wang, Siqi Geng, Fang Wang, Baoru Fang, Huifeng Qian, Ying Li, Yiqing Zhou, Yanping Chen, Zhangsen Yu(*), Natural Epigallocatechin-3-Gallocarboxylate Nanoformulation Loaded Doxorubicin to Construct a Novel and Low Cardiotoxicity Chemotherapeutic Drug for High-Efficiency Breast Cancer Therapy, Journal of Nanobiotechnology, 2024, 22(1): 793.
Qiang Feng, Hongting Xu, Xiaoyu Pan, Siqi Geng, Huifeng Qian, Chujie Wang, Ying Li, Jiaying Qin, Yiting Wu, Bangyi Zhou, Xiaoyu Liu, Zhiqiu Ye(*), Yingchun Xu(*), Zhangsen Yu(*), Antioxidation and Anti-Inflammatory Acitivity of Prussian Blue Nanozymes to Alleviate Acetaminophen Induced Acute Liver Injury, ACS Applied Nano Materials, 2023, 6(10): 8468-8481.
Siqi Geng, Qiang Feng, Chujie Wang, Ying Li, Jiaying Qin, Mingsheng Hou, Jiedong Zhou, Xiaoyu Pan, Fei Xu, Baoru Fang, Ke Wang, Zhangsen Yu(*), A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy Against Breast Cancer and Attenuated Doxorubicin Induced Cardiotoxicity, Journal of Nanobiotechnology, 2023, 21: 338.
Bangyi Zhou, Chenhui Yin, Qiang Feng, Yiting Wu, Xiaoyu Pan, Chuang Liu, Jinjin Tian, Siqi Geng, Kexin Wang, Jie Xing, Yi Cao, Pingbo Shou, Zhangsen Yu(*), Aiguo Wu(*), Polypyrrole Based Nanotheranostic Agent for MRI Guided Photothermal-Chemodynamic Synergistic Cancer Therapy, Nanoscale, 2021, 13(45): 19085-19097.
Pingbo Shou, Zhangsen Yu (*), Yiting Wu, Qiang Feng, Bangyi Zhou, Jie Xing, Chuang Liu, Jinqing Tu, Zhiqiu Ye, Xiaojuan Zhang, Zhenbo Lu, Luyun Zhang, Aiguo Wu(*), Zn(2+) Doped Ultra-Small Prussian blue Nanotheranostic Agent for Breast Cancer Photothermal Therapy under MR Imaging Guidance, Advanced Healthcare Materials, 2020, 9(1), 1900948.
申请/授权专利：
1. 吴爱国，俞樟森，杨方，李娟，《一种多波长激发、上/下转换荧光共存的多壳层结构的纳米发光材料及其制备方法》，申请号：201711173236.5。
2. 吴爱国，俞樟森，杨方，《一种上转换荧光成像系统及上转换荧光的成像方法》，申请号：201711174200.9。
3. 吴爱国，俞樟森，杨方，一种上转换荧光数字全息成像系统及数字全息成像方法，授权，专利号：ZL 2017 1 1173737.3。
4. 吴爱国，俞樟森，一种近红外荧光发射的纳米材料及其制备方法，申请号：201711173273.6。
5. 俞樟森，钱沁清，张建华，孙爱静，张衡，方剑，张小娟，一种食源性致病菌现场快速检测方法，授权，专利号：ZL 2018 1 0397550.X。
6. 俞樟森，寿平波，叶知秋，陆振波，丰强，吴逸婷，一种Zn(2+)掺杂超小粒径普鲁士蓝纳米探针的制备方法，申请号：201811247647.9。
7. 寿平波，俞樟森，屠金卿，叶知秋，丰强，周邦翼，吴逸婷，一种用于光辅助治疗实验的仪器，申请号：201910179117.3。
主持/参与项目：
浙江省基础公益研究计划项目，化疗药物心肌损伤相关研究，2023.01 - 2025.12，10万元，在研。
浙江省基础公益研究计划项目，纳米酶改善肝缺血再灌注损伤的机制研究，2024.01 - 2026.12，10万元，在研。
绍兴市科技计划项目，TNBC化疗/免疫协同治疗研究，2025.01 - 2027.12，10万元，在研。
绍兴市科技计划项目，肝癌射频消融/免疫协同治疗研究，2023.01 - 2025.12，20万元，在研。
浙江省基础公益研究计划项目，纳米酶在骨关节炎诊断及治疗相关研究，2022.01 - 2024.12，10万元，在研。
浙江省基础公益研究计划项目，肝癌声动力/免疫协同治疗研究，2021.01 - 2023.12，10万元，结题。
